Atwal; Jasvinder
Patent Applications and Registrations
Patent applications and USPTO patent grants for Atwal; Jasvinder.The latest application filed is for "modified antibody fcs and methods of use".
- Atwal; Jasvinder - San Carlos CA
- Atwal; Jasvinder - South San Francisco CA
| Patent | Date |
|---|---|
| Modified Antibody Fcs And Methods Of Use App 20220033520 - Lazar; Gregory A. ; et al. | 2022-02-03 |
| Anti-transferrin receptor antibodies and methods of use Grant 11,098,129 - Zhang , et al. August 24, 2 | 2021-08-24 |
| Antibodies Against BACE1 and Use Thereof for Neural Disease Immunotherapy App 20210206877 - Liu; Yichin ; et al. | 2021-07-08 |
| Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use Grant 11,008,403 - Liu , et al. May 18, 2 | 2021-05-18 |
| Anti-transferrin Receptor Antibodies And Methods Of Use App 20210087288 - Zhang; Yin ; et al. | 2021-03-25 |
| Antibodies against BACE1 and use thereof for neural disease immunotherapy Grant 10,882,920 - Liu , et al. January 5, 2 | 2021-01-05 |
| Anti-transferrin receptor antibodies and methods of use Grant 10,808,036 - Zhang , et al. October 20, 2 | 2020-10-20 |
| Anti-Transferrin Receptor Antibodies and Methods of Use App 20200123267 - Zhang; Yin ; et al. | 2020-04-23 |
| Anti-transferrin receptor antibodies and methods of use Grant 10,508,151 - Zhang , et al. Dec | 2019-12-17 |
| Anti-transferrin Receptor Antibodies And Methods Of Use App 20180134797 - Zhang; Yin ; et al. | 2018-05-17 |
| Anti-transferrin Receptor / Anti-bace1 Multispecific Antibodies And Methods Of Use App 20180057604 - Liu; Yichin ; et al. | 2018-03-01 |
| Nucleic acid molecules encoding for BACE1 antibodies Grant 9,879,094 - Atwal , et al. January 30, 2 | 2018-01-30 |
| Anti-transferrin Receptor Antibodies And Methods Of Use App 20180002433 - Zhang; Yin ; et al. | 2018-01-04 |
| Antibodies Against Bace1 And Use Thereof For Neural Disease Immunotherapy App 20170362339 - Liu; Yichin ; et al. | 2017-12-21 |
| Anti-transferrin receptor antibodies and methods of use Grant 9,708,406 - Zhang , et al. July 18, 2 | 2017-07-18 |
| Methods And Compositions For Neural Disease Immunotherapy App 20170058049 - Atwal; Jasvinder ; et al. | 2017-03-02 |
| Methods and compositions for neural disease immunotherapy Grant 9,453,079 - Atwal , et al. September 27, 2 | 2016-09-27 |
| Anti-transferrin Receptor Antibodies And Methods Of Use App 20150110791 - Zhang; Yin ; et al. | 2015-04-23 |
| Methods And Compositions For Neural Disease Immunotherapy App 20140286963 - Atwal; Jasvinder ; et al. | 2014-09-25 |
| BACE1 antibodies Grant 8,772,457 - Atwal , et al. July 8, 2 | 2014-07-08 |
| Methods And Compositions For Neural Disease Immunotherapy App 20120148599 - Atwal; Jasvinder ; et al. | 2012-06-14 |
| Modulators of neuronal regeneration Grant 7,943,329 - Atwal , et al. May 17, 2 | 2011-05-17 |
| Modulators Of Neuronal Regeneration App 20100047232 - Atwal; Jasvinder ; et al. | 2010-02-25 |
| ANTI-PirB ANTIBODIES App 20090285803 - Atwal; Jasvinder ; et al. | 2009-11-19 |
| Modulators of neuronal regeneration App 20090232794 - Tessier-Lavigne; Marc ; et al. | 2009-09-17 |
| Modulators of neuronal regeneration App 20090169542 - Atwal; Jasvinder ; et al. | 2009-07-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 